Skip Nav Destination
Progress in Tumor Research
Neuro-Oncology: Mansell Bequest Symposium on Advances in Neuro-Oncology, London, October 1984: ProceedingsAvailable to Purchase
S.Karger AG
Volume
29
Status:
Available
ISBN electronic:
978-3-318-04182-8
ISBN print:
978-3-8055-4054-4
Discontinued Book Series:
Progress in Tumor Research
Published online:
2015
Published in print:
1985
Neuro-Oncology: Mansell Bequest Symposium on Advances in Neuro-Oncology, London, October 1984: Proceedings
Edited by: F. Clifford Rose, W.S. Fields
https://doi.org/10.1159/isbn.978-3-318-04182-8
ISBN (print): 978-3-8055-4054-4
ISBN (electronic): 978-3-318-04182-8
Publisher: S.Karger AG
Published: 1985
Download citation file:
Digital Version
Pay-Per-View Access
$271.00
Print Version
Neuro-Oncology
$271.00
Table of Contents
-
1 - 11: Descriptive Epidemiology of Primary Intracranial Neoplasms1ByMary B. Codd;Mary B. CoddDepartment of Medical Statistics and Epidemiology, Mayo Clinic and Mayo Foundation, Rochester, Minn., USASearch for other works by this author on:Leonard T. KurlandLeonard T. KurlandDepartment of Medical Statistics and Epidemiology, Mayo Clinic and Mayo Foundation, Rochester, Minn., USASearch for other works by this author on:
-
12 - 16: Markers of the Malignant Glial PhenotypeByR. I. Freshney;R. I. FreshneyDepartment of Clinical Oncology, University of Glasgow and Beatson Institute for Cancer Research, Bearsden, Glasgow, UKSearch for other works by this author on:M. C. Frame;M. C. FrameDepartment of Clinical Oncology, University of Glasgow and Beatson Institute for Cancer Research, Bearsden, Glasgow, UKSearch for other works by this author on:C. M. MacDonald;C. M. MacDonaldDepartment of Clinical Oncology, University of Glasgow and Beatson Institute for Cancer Research, Bearsden, Glasgow, UKSearch for other works by this author on:E. Hart;E. HartDepartment of Clinical Oncology, University of Glasgow and Beatson Institute for Cancer Research, Bearsden, Glasgow, UKSearch for other works by this author on:R. Shaw;R. ShawDepartment of Clinical Oncology, University of Glasgow and Beatson Institute for Cancer Research, Bearsden, Glasgow, UKSearch for other works by this author on:M. Hassanzadah;M. HassanzadahDepartment of Clinical Oncology, University of Glasgow and Beatson Institute for Cancer Research, Bearsden, Glasgow, UKSearch for other works by this author on:M. G. FreshneyM. G. FreshneyDepartment of Clinical Oncology, University of Glasgow and Beatson Institute for Cancer Research, Bearsden, Glasgow, UKSearch for other works by this author on:
-
17 - 35: Stabilities and Characteristics of Brain Meninges-Colonizing Murine Melanoma CellsByGarth L. Nicolson;Garth L. NicolsonaDepartment of Tumor Biology, University of Texas, M. D. Anderson Hospital and Tumor Institute Houston, Tex., USA;Search for other works by this author on:Carolyn Van Pelt;Carolyn Van PeltbTexas Veterinary Medical Diagnostic Laboratory, Texas A&M University, College Station, Tex., USA;Search for other works by this author on:Tatsuro Irimura;Tatsuro IrimuraaDepartment of Tumor Biology, University of Texas, M. D. Anderson Hospital and Tumor Institute Houston, Tex., USA;Search for other works by this author on:Takanori KawaguchiTakanori KawaguchicDepartment of Pathology, Fukushima Medical School, Fukushima, JapanSearch for other works by this author on:
-
36 - 44: Recent Developments in Magnetic Resonance Imaging of CNS TumoursByG. M. BydderG. M. BydderDepartment of Diagnostic Radiology, Royal Postgraduate Medical School, London, UKSearch for other works by this author on:
-
45 - 49: Monoclonal Antibodies and GliomaByK. Sikora;K. SikoraLudwig Institute for Cancer Research, MRC Centre, Cambridge, UKSearch for other works by this author on:T. Alderson;T. AldersonLudwig Institute for Cancer Research, MRC Centre, Cambridge, UKSearch for other works by this author on:S. Chan;S. ChanLudwig Institute for Cancer Research, MRC Centre, Cambridge, UKSearch for other works by this author on:N. MarkhamN. MarkhamLudwig Institute for Cancer Research, MRC Centre, Cambridge, UKSearch for other works by this author on:
-
50 - 56: Positron Emission Tomography in Brain Tumour ImagingByD. G. T. Thomas;D. G. T. ThomasaInstitute of Neurology, The National Hospital, andSearch for other works by this author on:D. J. Brooks;D. J. BrooksbMRC Cyclotron Unit, Hammersmith Hospital, London, UKSearch for other works by this author on:R. P. BeaneyR. P. BeaneybMRC Cyclotron Unit, Hammersmith Hospital, London, UKSearch for other works by this author on:
-
57 - 77: Diagnosis of Cerebral Neoplasms Using Monoclonal AntibodiesByH. B. Coakham;H. B. CoakhamaDepartments of Neurosurgery andSearch for other works by this author on:J. A. Garson;J. A. GarsonbNeuropathology, Frenchay Hospital, Bristol, UK;Search for other works by this author on:B. Brownell;B. BrownellbNeuropathology, Frenchay Hospital, Bristol, UK;Search for other works by this author on:J. T. KemsheadJ. T. KemsheadcImperial Cancer Research Fund Oncology Laboratory, Institute of Child Health, London, UKSearch for other works by this author on:
-
78 - 84: Radioimmunolocalisation of Cerebral TumoursByR. H. J. BegentR. H. J. BegentCancer Research Campaign Laboratories, Department of Medical Oncology, Charing Cross and Westminster Medical School, London, UKSearch for other works by this author on:
-
85 - 92: A Monoclonal Antibody, UJ13A, Used for Radioimmunolocalisation of Neuroblastoma in an Animal Model and PatientsByA. Goldman;A. GoldmanaHospital for Sick Children, andbImperial Cancer Research Fund Oncology Laboratory, Institute of Child Health, London, UKSearch for other works by this author on:J. Pritchard;J. PritchardaHospital for Sick Children, andSearch for other works by this author on:J. KemsheadJ. KemsheadbImperial Cancer Research Fund Oncology Laboratory, Institute of Child Health, London, UKSearch for other works by this author on:
-
93 - 104: Diagnosis of Spinal Cord and Cauda equina MetastasesByM. M. SharrM. M. SharrSouth-East Thames Regional Neurosurgical Unit, Brook General Hospital, London, UKSearch for other works by this author on:
-
105 - 115: Sensitivity and Specificity of Cerebrospinal Fluid Biochemical Markers of Central Nervous System MetastasesByB. W. Ongerboer de Visser;B. W. Ongerboer de VisserClinical Division of the Netherlands Cancer Institute, and the Departments of Clinical Chemistry and Neurology of the Slotervaart Hospital, Amsterdam, The NetherlandsSearch for other works by this author on:A. P. van Zanten;A. P. van ZantenClinical Division of the Netherlands Cancer Institute, and the Departments of Clinical Chemistry and Neurology of the Slotervaart Hospital, Amsterdam, The NetherlandsSearch for other works by this author on:A. Twijnstra;A. TwijnstraClinical Division of the Netherlands Cancer Institute, and the Departments of Clinical Chemistry and Neurology of the Slotervaart Hospital, Amsterdam, The NetherlandsSearch for other works by this author on:W. J. Nooyen;W. J. NooyenClinical Division of the Netherlands Cancer Institute, and the Departments of Clinical Chemistry and Neurology of the Slotervaart Hospital, Amsterdam, The NetherlandsSearch for other works by this author on:A. A. M. HartA. A. M. HartClinical Division of the Netherlands Cancer Institute, and the Departments of Clinical Chemistry and Neurology of the Slotervaart Hospital, Amsterdam, The NetherlandsSearch for other works by this author on:
-
116 - 122: Animal Models: Blood-Brain Barrier and PharmacologyByWilliam R. ShapiroWilliam R. ShapiroGeorge C. Cotzias Laboratory of Neuro-Oncology, Memorial Sloan-Kettering Cancer Center, New York, N. Y., USASearch for other works by this author on:
-
123 - 130: Chemosensitivity Testing in the Treatment of Malignant GliomasByJ. L. DarlingJ. L. DarlingGough-Cooper Department of Neurological Surgery, Institute of Neurology, National Hospital, London, UKSearch for other works by this author on:
-
131 - 139: New Drugs and New Delivery TechniquesByLynn G. Feun;Lynn G. FeunaDepartments of Neuro-Oncology,Search for other works by this author on:Chusilp Charnsangavej;Chusilp CharnsangavejbDiagnostic Radiology andSearch for other works by this author on:Niramol Savaraj;Niramol SavarajcChemotherapy Research, University of Texas at Houston, M. D. Anderson Hospital and Tumor Institute, Houston, Tex., USASearch for other works by this author on:C. Humberto Carrasco;C. Humberto CarrascobDiagnostic Radiology andSearch for other works by this author on:Cesare Gianturco;Cesare GianturcobDiagnostic Radiology andSearch for other works by this author on:Wai-Kwan A. YungWai-Kwan A. YungaDepartments of Neuro-Oncology,Search for other works by this author on:
-
140 - 151: Monoclonal Antibodies for Targeting Chemotherapeutic AgentsByR. W. BaldwinR. W. BaldwinCancer Research Campaign Laboratories, University of Nottingham, University Park, Nottingham, UKSearch for other works by this author on:
-
152 - 166: Current Status of Chemotherapy of Brain TumoursByJ. HildebrandJ. HildebrandService de Neurologie, Hôpital Erasme, Université Libre de Bruxelles, BelgiumSearch for other works by this author on:
-
167 - 176: Chemotherapy for Brain MetastasesByE. S. NewlandsE. S. NewlandsDepartment of Medical Oncology, Cancer Research Campaign Laboratories, Charing Cross Hospital and Westminster Medical School, London, UKSearch for other works by this author on:
-
177 - 182: Neurotoxicity of High-Dose Cytosine ArabinosideByM. J. Barnett;M. J. BarnettaImperial Cancer Research Fund Department of Medical Oncology andSearch for other works by this author on:T. S. Ganesan;T. S. GanesanaImperial Cancer Research Fund Department of Medical Oncology andSearch for other works by this author on:J. H. Waxman;J. H. WaxmanaImperial Cancer Research Fund Department of Medical Oncology andSearch for other works by this author on:M. A. Richards;M. A. RichardsaImperial Cancer Research Fund Department of Medical Oncology andSearch for other works by this author on:B. F. Smith;B. F. SmithbDepartment of Pathology, St. Bartholomew’s Hospital, London, UKSearch for other works by this author on:A. Z. S. Rohatiner;A. Z. S. RohatineraImperial Cancer Research Fund Department of Medical Oncology andSearch for other works by this author on:H. S. Dhaliwal;H. S. DhaliwalaImperial Cancer Research Fund Department of Medical Oncology andSearch for other works by this author on:M. L. Slevin;M. L. SlevinaImperial Cancer Research Fund Department of Medical Oncology andSearch for other works by this author on:T. A. ListerT. A. ListeraImperial Cancer Research Fund Department of Medical Oncology andSearch for other works by this author on:
-
183 - 189: Neurotoxicity of High-Dose Ara-C and Intracarotid ChemotherapyByW. K. A. Yung;W. K. A. YungDepartment of Neuro-Oncology, University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Tex., USASearch for other works by this author on:Te-Long Hwang;Te-Long HwangDepartment of Neuro-Oncology, University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Tex., USASearch for other works by this author on:J. Martinez-Prieto;J. Martinez-PrietoDepartment of Neuro-Oncology, University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Tex., USASearch for other works by this author on:Ya-Yen Lee;Ya-Yen LeeDepartment of Neuro-Oncology, University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Tex., USASearch for other works by this author on:L. G. FeunL. G. FeunDepartment of Neuro-Oncology, University of Texas, M. D. Anderson Hospital and Tumor Institute, Houston, Tex., USASearch for other works by this author on:
-
190 - 196: Polyneuropathy Induced by CisplatinByB. W. Ongerboer de Visser;B. W. Ongerboer de VisserClinical Division of the Netherlands Cancer Institute, Amsterdam, The NetherlandsSearch for other works by this author on:G. TiessensG. TiessensClinical Division of the Netherlands Cancer Institute, Amsterdam, The NetherlandsSearch for other works by this author on:
-
197 - 202: Central Nervous System Toxicity of InterferonByA. Z. S. Rohatiner;A. Z. S. RohatineraICRF Department of Medical Oncology andSearch for other works by this author on:P. Prior;P. PriorbDepartment of Neurological Sciences, St. Bartholomew’s Hospital, andSearch for other works by this author on:A. Burton;A. BurtonbDepartment of Neurological Sciences, St. Bartholomew’s Hospital, andSearch for other works by this author on:T. A. ListerT. A. ListeraICRF Department of Medical Oncology andSearch for other works by this author on:
-
203 - 209: Radiotherapy for Cerebral MetastasesByD. AshD. AshCookridge Hospital, Leeds, UKSearch for other works by this author on:
-
210 - 218: The Risk of Cerebral Radionecrosis in Relation to Dose, Time and Fractionation: A Follow-Up StudyByJ. E. Marks;J. E. MarksMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Mo., USASearch for other works by this author on:J. WongJ. WongMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Mo., USASearch for other works by this author on:
-
219 - 224: Combined Modality Treatment of Malignant GliomaByWilliam R. ShapiroWilliam R. ShapiroDepartment of Neurology, Memorial Sloan-Kettering Cancer Center, New York, N.Y., USASearch for other works by this author on:
-
225 - 234: Treatment of Malignant Epidural Cord and Cauda equina CompressionByTali Siegal;Tali SiegalaDepartments of Neurology and Oncology, Hadassah University Hospital, Jerusalem, Israel;Search for other works by this author on:Tzony SiegalTzony SiegalbThe Spinal Surgery Unit, The Beilinson Medical Center, Petah Tikva, IsraelSearch for other works by this author on:
-
235 - 248: Medical and Oncological Management of Pediatric Brain TumorsByJ. van EysJ. van EysUniversity of Texas, M. D. Anderson Hospital and Tumor Institute, Texas Medical Center, Houston, Tex., USASearch for other works by this author on:
-
249 - 255: Removal of Malignant Cells from Bone Marrow Using Magnetic Microspheres and Monoclonal AntibodiesByJ. T. Kemshead;J. T. KemsheadICRF Oncology Laboratory, Institute of Child Health and Medical Oncology Unit, St. Bartholomew’s Hospital London, UK; Institute of Industrial Chemistry, Norwegian Institute of Technology, University of Trondheim, Norway; Jet Propulsion Laboratory, California Institute of Technology, Pasadena, Calif., USA; Centre Leon Berard, Lyon, FranceSearch for other works by this author on:J. G. Treleaven;J. G. TreleavenICRF Oncology Laboratory, Institute of Child Health and Medical Oncology Unit, St. Bartholomew’s Hospital London, UK; Institute of Industrial Chemistry, Norwegian Institute of Technology, University of Trondheim, Norway; Jet Propulsion Laboratory, California Institute of Technology, Pasadena, Calif., USA; Centre Leon Berard, Lyon, FranceSearch for other works by this author on:F. M. Gibson;F. M. GibsonICRF Oncology Laboratory, Institute of Child Health and Medical Oncology Unit, St. Bartholomew’s Hospital London, UK; Institute of Industrial Chemistry, Norwegian Institute of Technology, University of Trondheim, Norway; Jet Propulsion Laboratory, California Institute of Technology, Pasadena, Calif., USA; Centre Leon Berard, Lyon, FranceSearch for other works by this author on:J. Ugelstad;J. UgelstadICRF Oncology Laboratory, Institute of Child Health and Medical Oncology Unit, St. Bartholomew’s Hospital London, UK; Institute of Industrial Chemistry, Norwegian Institute of Technology, University of Trondheim, Norway; Jet Propulsion Laboratory, California Institute of Technology, Pasadena, Calif., USA; Centre Leon Berard, Lyon, FranceSearch for other works by this author on:A. Rembaum;A. RembaumICRF Oncology Laboratory, Institute of Child Health and Medical Oncology Unit, St. Bartholomew’s Hospital London, UK; Institute of Industrial Chemistry, Norwegian Institute of Technology, University of Trondheim, Norway; Jet Propulsion Laboratory, California Institute of Technology, Pasadena, Calif., USA; Centre Leon Berard, Lyon, FranceSearch for other works by this author on:T. PhilipT. PhilipICRF Oncology Laboratory, Institute of Child Health and Medical Oncology Unit, St. Bartholomew’s Hospital London, UK; Institute of Industrial Chemistry, Norwegian Institute of Technology, University of Trondheim, Norway; Jet Propulsion Laboratory, California Institute of Technology, Pasadena, Calif., USA; Centre Leon Berard, Lyon, FranceSearch for other works by this author on:
-
256 - 268: Tumors, Tools, and Technology: The Role of the NeurosurgeonByR. P. MoserR. P. MoserThe University of Texas System Cancer Center, M. D. Anderson Hospital and Tumor Institute, Houston, Tex., USASearch for other works by this author on:
